15485-72-0

Basic information

• Product Name: 4H-1-Benzopyran-2-carboxylic acid, 7-hydroxy-4-oxo-3-phenyl-, ethyl ester
• CAS NO: 15485-72-0
• Molecular Formula: C18H14O5
• Molecular Weight: 310.306
• Mol File: 15485-72-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4H-1-Benzopyran-2-carboxylic acid, 7-hydroxy-4-oxo-3-phenyl-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-1-Benzopyran-2-carboxylic acid, 7-hydroxy-4-oxo-3-phenyl-, ethyl ester(15485-72-0)
• EPA Substance Registry System: 4H-1-Benzopyran-2-carboxylic acid, 7-hydroxy-4-oxo-3-phenyl-, ethyl ester(15485-72-0)

Safety Data

• Hazardous Substances Data: 15485-72-0(Hazardous Substances Data)

Upstream product

• 3669-41-8 1-(2,4-dihydroxyphenyl)-2-phenylethanone 
• 4755-77-5 Ethyl oxalyl chloride 
• 108-46-3 recorcinol 
• 103-82-2 phenylacetic acid 

Downstream Products

• 35212-50-1 ethyl 7-methoxy-4-oxo-3-phenyl-4H-chromene-2-carboxylate 
• 39232-48-9 7-benzothiazol-2-ylmethoxy-4-oxo-3-phenyl-4H-chromene-2-carboxylic acid 
• 35212-51-2 7-methoxy-4-oxo-3-phenyl-4H-chromene-2-carboxylic acid 
• 13057-72-2 7-hydroxyisoflavone 
• 39232-49-0 7-(2-methyl-thiazol-4-ylmethoxy)-4-oxo-3-phenyl-4H-chromene-2-carboxylic acid ethyl ester 
• 39238-04-5 7-hydroxy-4-oxo-3-phenyl-4H-chromene-2-carboxylic acid 
• 39232-47-8 IBS_STOCK₁S-24991 

Relevant articles and documents

Synthesis of daidzin analogues as potential agents for alcohol abuse

Daidzin, the active principle of an herbal remedy for 'alcohol addiction', has been shown to reduce alcohol consumption in all laboratory animals tested to date. Correlation studies using structural analogues of daidzin suggests that it acts by raising the monoamine oxidase (MAO)/mitochondrial aldehyde dehydrogenase (ALDH-2) activity ratio (J. Med. Chem. 2000, 43, 4169). Structure-activity relationship (SAR) studies on the 7-O-substituted analogues of daidzin have revealed structural features important for ALDH-2 and MAO inhibition (J. Med. Chem. 2001, 44, 3320). We here evaluated effects of substitutions at 2, 5, 6, 8, 3′ and 4′ positions of daidzin on its potencies for ALDH-2 and MAO inhibition. Results show that analogues with 4′-substituents that are small, polar and with hydrogen bonding capacities are most potent ALDH-2 inhibitors, whereas those that are non-polar and with electron withdrawing capacities are potent MAO inhibitors. Analogues with a 5-OH group are less potent ALDH-2 inhibitors but are more potent MAO inhibitors. All the 2-, 6-, 8- and 3′-substituted analogues tested so far do not inhibit ALDH-2 and/or have decreased potencies for MAO inhibition. This, together with the results obtained from previous studies, suggests that a potent antidipsotropic analogue would be a 4′,7-disubstituted isoflavone. The 4′-substituent should be small, polar, and with hydrogen bonding capacities such as, -OH and -NH2; whereas the 7-substituent should be a straight-chain alkyl with a terminal polar function such as -(CH 2)n-OH with 2≤n ≤6, -(CH2) n-COOH with 5≤n ≤10, or -(CH2)n-NH 2 with n ≥4.

COMPOUNDS USEFUL FOR THE INHIBITION OF ALDH

The present invention provides novel antidipsotropic compounds. The invention further provides methods of inhibiting ALDH-2 using the compounds described herein. Methods for modulating alcohol consumption, alcohol dependence and/or alcohol abuse by administering the compounds of the invention to an individual are also provided. The present invention further provides a rationale for designing additional novel antidipsotropic compounds.